ITGA6 and cancer: AKT is regarded as a primary mediator of resistance, and ITGA6 plays a crucial role in cancer resistance by modulating the MAPK/ERK and PI3K/AKT survival signaling pathways [6,10,12,21,22,54,55,73,103,120,137,144].